CXCR2 is a negative regulator of p21 in p53-dependent and independent manner via Akt-mediated Mdm2 in ovarian cancerRosa Mistica C. Ignacio(Meharry Medical College), Deok‐Soo Son(Meharry Medical College)OncotargetJanuary 13, 201810.18632/oncotarget.24231Cited by 19SaveCiteExport RISWatch citationsRelated PapersCXCR2-Driven Ovarian Cancer Progression Involves Upregulation of Proinflammatory Chemokines by Potentiating NF-κB Activation via EGFR-Transactivated Akt Signaling|PLoS ONE|2013|62Inhibitory Effect of Tumor Suppressor p53 on Proinflammatory Chemokine Expression in Ovarian Cancer Cells by Reducing Proteasomal Degradation of IκB|PLoS ONE|2012|52Characteristics of chemokine signatures elicited by EGF and TNF in ovarian cancer cells|Journal of Inflammation|2013|38NF-κB-Mediated CCL20 Reigns Dominantly in CXCR2-Driven Ovarian Cancer Progression|PLoS ONE|2016|36Intermittent Fasting Attenuates Obesity-Induced Triple-Negative Breast Cancer Progression by Disrupting Cell Cycle, Epithelial–Mesenchymal Transition, Immune Contexture, and Proinflammatory Signature|Nutrients|2024|9